window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in Healthcare

  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    Outcome Capital launches advisory board to advance innovation in pharmacy and related services

    Outcome Capital, a life sciences and healthcare advisory and investment [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data

    myTomorrows secures $29 million from Avego to expand global access to pre-approval treatments

    myTomorrows has raised $29 million from Avego to support its [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    M42 partners with Medical Tourism Association and Mastercard to expand UAE’s global patient reach

    M42, a global health leader leveraging artificial intelligence, technology, and [...]

    May 5, 2026
  • Digital & Data,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Gifthealth streamlines patient access with AI-driven pharmacy logistics and direct-to-patient model

    As supply chain pressures and rising drug costs challenge patients [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Lithuania’s vice minister Daniel Naumovas on health innovation: “We want patients to feel they can get the best treatment here”

    Daniel Naumovas is a scientist, a teacher and, at 31, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Medical devices,Pharmaceuticals and therapeutics

    Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation

    Lithuania’s life sciences sector is preparing to showcase its rapid [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Medical devices,Opinion & Events

    AI tool could spot hospital infections up to 72 hours early

    Sanome’s MEMORI becomes the first UK-developed AI medical device to [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Briya launches clinical-grade AI assistant for accelerating medical and epidemiological research

    New AI platform designed to support faster discovery, better study [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • PET imaging reveals widespread synaptic loss in schizophrenia
    Categories: Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Revita maintains GLP-1 weight loss one year after treatment discontinuation in REMAIN-1 trial
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development
  • Two-minute digital test matches clinical benchmarks for Alzheimer’s trial screening
    Categories: Clinical & Regulatory, Digital & Data, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top